Other news to note for April 28, 2020

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Ablexis, Adamis, Adaptvac, Agastiya, Akshaya, Arcturus, Armagen, Audax Medical, Avacta, Bayer, Berkeley Lights, Bioaegis, Biosig, Biovista, Clover, Cocrystal, Cutia, Cyclica, Cytiva, Dynavax, Emergent Biosolutions, Epimab, Faron, Gilead, Hansoh, Hemogenyx, Hoth, Immunic, Imquest, Innovation, Insmed, JCR, Johnson & Johnson, Kamada, Kedrion, Linical, Menlo, Merck, Moleculin, Nascent, Nextgen Vaccines, Nikang, Novelstem, Opgen, Orifarm Group, Pharnext, Prothera, Q Biomed, Recce, Recursion, Redhill, Santhera, Scancell, Sengenics, Takeda, Tracon, Trilink, Valneva, Valo, Vaxart, Vertex, Viravaxx, Vivacelle, Voltron, Wize.

Financings for April 28, 2020

Biopharmas in Asia-Pacific raising money in public or private financings, including: Bugworks Research, Migvax, Pluristem.

Appointments and advancements for April 28, 2020

New hires and promotions in the biopharma industry in Asia-Pacific, including: Nanomab Technology.

Regulatory front for April 28, 2020

The latest global regulatory news, changes and updates affecting biopharma, including: Biomedical Advanced Research and Development Authority, COVID-19 EMA Pandemic Task Force, Cybersecurity and Infrastructure Security Agency, EMA, European Commission, FDA, Heads of Medicines Agencies, National Institute for Health and Care Excellence, NIH, Therapeutic Goods Administration, U.S. Cyber Command, U.S. House and Senate, Wuhan Institute of Virology.

Clinical data for April 21-27, 2020

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astrazeneca, Atyr, CTI Biopharma, Daiichi Sankyo, Hua Medicine, Immutep, Regeneron, Romark, Sanofi, Theravance.

Regulatory actions for April 21-27, 2020

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Algernon, Arch Biopartners, Beigene, Biontech, Biosig Technologies, Caladrius, Carsgen, Chugai, Clarity, Cstone, Diffusion, Eli Lilly, Halozyme, Hope Biosciences, Immuneoncia, Innovent Biologics, Janssen, Mateon, Oryzon Genomics, Pfizer, Rafael, Revive, Samsung Biologics, Shanghai Green Valley, Takeda, Viralclear, Vitro Diagnostics.

No Comments